Global ECMO Machines Market Outlook to 2028

Global Extracorporeal Membrane Oxygenation Machines Market Overview 

The Global Extracorporeal Membrane Oxygenation (ECMO) Machines Market was valued at USD 308.1 million in 2023. This growth is driven by increasing incidences of cardiopulmonary diseases, technological advancements in ECMO machines, and rising awareness about ECMO procedures. The demand for ECMO machines is further propelled by the growing number of cardiac surgeries and the need for advanced healthcare facilities to manage critical patients effectively. 

The key players in the market include Medtronic, Getinge Group, Liva Nova PLC, Terumo Corporation, and Abbott Laboratories. These companies dominate the market through continuous innovation, extensive distribution networks, and strategic collaborations. They focus on expanding their product portfolios and geographical presence to maintain a competitive edge. 

In 2023, Medtronic announced the launch of a next-generation ECMO system, which offers improved patient monitoring and system integration. This new system is designed to enhance patient outcomes and streamline clinical workflows. The launch represents a significant advancement in ECMO technology, aiming to reduce complications and improve the efficiency of extracorporeal life support. 

The United States, dominates the market due to its advanced healthcare infrastructure and high adoption rate of innovative medical technologies. The region's dominance is attributed to significant healthcare expenditure, extensive research and development activities, and a robust presence of key market players. 

Global Extracorporeal Membrane Oxygenation Machines Market Segmentation 

The Global ECMO Machines Industry can be segmented in various factors like product, application, and region. 

By Product: The market is segmented by product type into veno-arterial (VA), veno-venous (VV), and arterio-venous (AV) ECMO machines. In 2023, veno-arterial ECMO machines held the dominant market share, due to the VA ECMO's critical role in providing cardiac and respiratory support in patients with severe cardiac dysfunction. The increasing incidence of cardiac arrests and the effectiveness of VA ECMO in managing such conditions contribute to its market leadership. 

By Region: The market is segmented by region into North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East & Africa (MEA). In 2023, North America dominated the market with a share due to the region's advanced healthcare infrastructure, high healthcare expenditure. The U.S. government's initiatives to improve critical care services and the region's high prevalence of cardiopulmonary diseases further support this dominance. 

By Application: The market is also segmented by application into respiratory, cardiac, and extracorporeal cardiopulmonary resuscitation (ECPR). In 2023, the respiratory application segment held a dominant market share due to the rising prevalence of respiratory disorders such as COPD and ARDS, which require advanced respiratory support systems like ECMO.  

Global Extracorporeal Membrane Oxygenation Machines Market Competitive Landscape 

Company
 

Establishment Year 

Headquarters 

Medtronic 

1949 

Minneapolis, MN, USA 

Getinge Group 

1904 

Gothenburg, Sweden 

Liva Nova PLC 

2015 

London, UK 

Terumo Corporation 

1921 

Tokyo, Japan 

Abbott Laboratories 

1888 

Abbott Park, IL, USA 

Liva Nova PLC: In 2023, Liva Nova PLC acquired Tandem Life, a prominent ECMO systems manufacturer, for USD 250 million. This acquisition aims to strengthen Liva Nova's position in the ECMO market by integrating Tandem Life's advanced technologies and expanding its product offerings. The strategic move is expected to boost Liva Nova's market share and enhance its competitive edge in the ECMO segment. 

Terumo Corporation: In 2023, Terumo Corporation announced plans to double its ECMO production capacity to meet rising demand. This initiative aims to enhance the availability of ECMO systems, crucial for treating severe respiratory and cardiac conditions, thereby advancing critical care technology during the ongoing healthcare challenges. 

Global Extracorporeal Membrane Oxygenation Machines Market Analysis 

Market Growth Drivers 

Increasing Incidences of Cardiopulmonary Diseases: According to the World Health Organization (WHO), 17.9 million people die each year from cardiovascular diseases. In the U.S. alone, the American Heart Association reported that there were 805,000 heart attacks in 2024. This increasing burden of cardiopulmonary diseases is driving the demand for advanced treatment options like ECMO machines, which provide critical support to patients with severe heart and lung conditions. 

Technological Advancements in ECMO Machines: The ECMO machines market is shown technological advancements aimed at improving patient outcomes and reducing complications. In 2024, new ECMO systems with integrated artificial intelligence (AI) capabilities were introduced, allowing for better patient monitoring and decision-making. These advancements enhance the efficiency and effectiveness of ECMO procedures, thereby increasing their adoption in healthcare facilities. 

Rising Number of Cardiac Surgeries: The number of cardiac surgeries performed globally is increasing due to the growing prevalence of heart diseases and the availability of advanced surgical techniques. In 2024, over 1 million cardiac surgeries were performed worldwide, according to the Global Surgery Journal. The need for postoperative cardiac support is driving the demand for ECMO machines, which play a crucial role in patient recovery following complex cardiac procedures. 

Market Challenges
 

High Cost of ECMO Machines and Procedures: One of the primary challenges in the ECMO machines market is the high cost associated with the equipment and procedures. In 2024, the average cost of an ECMO machine was around USD 150,000. Additionally, the cost of operating an ECMO machine, including specialized staff and maintenance, can exceed USD 2,500 per day. These high costs limit the accessibility of ECMO technology, especially in low-income regions, posing a significant challenge to market growth.  

Risk of Complications and Adverse Events: The use of ECMO machines is associated with a risk of complications such as bleeding, infections, and mechanical failures. A report by the National Institutes of Health (NIH) in 2024 highlighted that 40% of ECMO patients experience at least one major complication. These risks can deter healthcare providers from using ECMO machines, thereby impacting market growth. 

Government Initiatives 

Japan's National Healthcare Enhancement Program: In 2024, the Nordic Health Summit Japan aims to foster collaboration between Nordic healthcare innovations and Japanese stakeholders. Scheduled for April 25th in Tokyo, this event will connect Nordic health tech companies with Japanese pharmaceutical firms, investors, and medical device companies, promoting investment and partnerships in the healthcare sector. 

India's Critical Care Improvement Scheme: The Indian government launched the Critical Care Improvement Scheme in 2024, to enhance critical care infrastructure in public hospitals. The scheme includes funding for the procurement of ECMO machines and training programs for medical professionals. This initiative aims to improve access to advanced critical care services in India. 

Global Extracorporeal Membrane Oxygenation Machines Market Future Outlook 

The future trends in the market include the integration of artificial intelligence, expansion in emerging markets, development of portable ECMO systems, and efforts to reduce costs and improve accessibility. 

Future Market Trends 

Development of Portable ECMO Systems: The coming years will witness the development and commercialization of portable ECMO systems, allowing for greater flexibility and mobility in patient care. These portable systems will enable the use of ECMO in pre-hospital settings, during transport, and in remote locations, expanding the reach of ECMO technology.  

Focus on Cost Reduction and Accessibility: Efforts to reduce the cost of ECMO machines and procedures will drive market growth over the next five years. Manufacturers will focus on developing cost-effective ECMO solutions and streamlining production processes to make ECMO technology more accessible.
Please Note: It will take 5-7 business days to complete the report upon order confirmation